The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
To assess the long-term safety and toleration of eplerenone in the children aged 6 to 16
years with high blood pressure. The study will last at least 1 year and about 140 patients
will participate.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.